Scholars Central

Conference abstract

Using monoclonal antibodies to understand the molecular basis for the cross bactericidal activity of NHBA antigen

Authors: Facciotti C, Bertoldi I, Galli B, Bartolini E, Donnarumma D, Lo Surdo, P Norais, N Santini, L Masignani, Giuliani M

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

T he Neisserial Heparin Binding Antigen (NHBA) is a protective antigen of N. meningitidis and is one of the components of the recently licensed vaccine Bexsero. NHBA was demonstrated to be an important virulence factor and to be able to elicit a robust immune response in humans against meningococcal strains expressing homologous and heterologous NHBA peptides. In order to better understand the cross protective nature of NHBA we performed a screening with the purpose to obtain monoclonal antibodies (mAbs) to be used as tools in the process of characterization. Mice were immunized with different forms of recombinant NHBA peptide 2, the same peptide present in the Bexsero formulation. When tested in the SBA assay, two of the new mAbs displayed bactericidal activity and other two mAbs were bacteriostatic against meningococcal strains expressing the homologous protein. Antibody binding and antibody affinity were measured on the recombinant protein by enzyme-linked immunosorbent assay (ELISA) and Surface Plasmon Resonance (SPR) experiments, respectively, whereas Fluorescence-activated cell sorter (FACS) analysis was used to detect the native protein on bacterial surface. Cross-bactericidal activity was assayed by testing the selected mAbs on a panel of MenB strains expressing different NHBA peptides. Finally, a plethora of epitope mapping techniques, including protein chip analysis on NHBA fragments and Hydrogen-Deuterium Exchange (HDX-MS) were adopted to precisely map the position of the recognized epitopes. By this approach we have mapped protective epitopes on NHBA and studied their possible role on NHBA cross bactericidal activity.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Vaccines & Vaccination.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Facciotti C”
  • BylineArticles whose byline prints “Bertoldi I”
  • BylineArticles whose byline prints “Galli B”
  • BylineArticles whose byline prints “Bartolini E”
  • BylineArticles whose byline prints “Donnarumma D”
  • BylineArticles whose byline prints “Lo Surdo”
  • BylineArticles whose byline prints “P Norais”
  • BylineArticles whose byline prints “N Santini”